Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States.
about
Hepatitis C virus and type 2 diabetesNAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic ManifestationsChemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agentsHepatitis C and insulin action: An intimate relationshipRole of dipeptidyl peptidase-4 inhibitors in new-onset diabetes after transplantationSteatosis and hepatitis CHepatitis C virus infection and type 1 and type 2 diabetes mellitusModeling HCV disease in animals: virology, immunology and pathogenesis of HCV and GBV-B infectionsHepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis CAssociation of hepatitis C virus infection and diabetes in central TunisiaHepatitis C Virus infection in apparentenly healthy individuals with family history of diabetes in Vom, Plateau State NigeriaThe impact of hepatitis C virus coinfection on HIV-related kidney disease: a systematic review and meta-analysisMolecular mechanisms of insulin resistance in chronic hepatitis CSupplementing Conventional Treatment with Pycnogenol® May Improve Hepatitis C Virus-Associated Type 2 Diabetes: A Mini ReviewFatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIVInterferon therapy in hepatitis C leading to chronic type 1 diabetesNew-onset diabetes mellitus after kidney transplantation: Current status and future directionsHepatitis C virus induced a novel apoptosis-like death of pancreatic beta cells through a caspase 3-dependent pathwayHepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis.Hepatitis C virus infection promotes hepatic gluconeogenesis through an NS5A-mediated, FoxO1-dependent pathway.Association of Hepatitis C Virus Infection with Type II Diabetes in Ethiopia: A Hospital-Based Case-Control StudyThe association of hepatitis C virus infection and post-liver transplant diabetes: data from 17 000 HCV-infected transplant recipients.Chronic hepatitis C treatment patterns in African American patients: an update.Pregnancy complications associated with hepatitis C: data from a 2003-2005 Washington state birth cohortNeither diabetes mellitus nor overweight is a risk factor for hepatocellular carcinoma in a dual HBV and HCV endemic area: community cross-sectional and case-control studies.Community-based cross-sectional study: the association of lipids with hepatitis C seropositivity and diabetes mellitus.Immunological alterations in hepatitis C virus infection.Association between hepatitis B virus infection and metabolic syndrome: a retrospective cohort study in Shanghai, China.Reversal, maintenance or progression: what happens to the liver after a virologic cure of hepatitis C?The concomitant use of second-generation antipsychotics and long-term antiretroviral therapy may be associated with increased cardiovascular risk.Mechanisms and significance of liver steatosis in hepatitis C virus infectionHepatitis B and C virus infection and diabetes mellitus: A cohort study.Prevalence of type 2 diabetes in Algerian patients with hepatitis C virus infectionRelationship of hepatitis C virus infection with diabetes in the U.S. population.Relationship of liver stiffness and controlled attenuation parameter measured by transient elastography with diabetes mellitus in patients with chronic liver disease.Sustained virologic response to antiviral therapy for chronic hepatitis C virus infection: a cure and so much more.Predicting the probable outcome of treatment in HCV patients.Chemokine antagonism in chronic hepatitis C virus infectionUnderstanding diabetes in patients with HIV/AIDS
P2860
Q24658049-D5D78F44-1B59-4FE6-8C5F-1C7343B50379Q26745576-149AEDB6-F293-4DD1-936A-A8D3D33729AFQ26772302-12CD7329-3CA6-4FCC-81FE-34FB2F51F48CQ26775000-B5D0B781-E3D4-4A24-A968-63A359A76D67Q26778329-F2941A9B-D79F-4DF1-8BA4-B01626144CB4Q26798101-65F60FF0-6C26-45D8-B98C-A1E933BE3580Q26829202-28D9D4E1-8388-45C5-93CB-9FEEBAE27909Q27002381-76D8DC55-B385-4737-B3AC-ABB5448BD6E8Q27477554-CA4A4ED4-8794-4C39-8B6E-EF3C88FAB771Q27477981-516B48A9-C1A5-45CC-80BB-5B88FE8D6E3EQ27488739-061C63A4-572F-4B1E-BB73-CB11D271B798Q27489026-8228E2C1-D586-451C-AC7E-F5B6BE813A4EQ27489415-341FCC7B-0BF5-4917-BB1D-79F58F535E69Q27489665-0133345D-7029-44C5-B1B9-0DD23488622FQ28068362-D475E537-644D-4216-8D4A-0B972B81A9B9Q28079826-7B93B68A-F8CF-40DC-9BCF-468FA6DF6B05Q28080876-4EF6DEC2-1E98-4B8B-B51F-B650F0E0A3C4Q28083882-CD58A39C-3058-4E28-AD78-EC04163BB5FEQ28728915-C4715E3C-ECD0-4553-AC87-692867A51189Q30360538-0EB7CB7B-E787-462C-BB43-A2B2CDBC990CQ30395512-29E35373-642E-4B92-B2D2-C7EC9E2A2DF9Q30422090-D5F33D78-598E-4C37-87CC-B8A2B9115908Q30870794-8EDC060E-39FF-48FB-B251-B879622017EAQ33212476-44B1CA00-E7B1-4B99-82A4-F0BD6AB7A713Q33335491-F8E1A7E5-2A9E-4D02-9A4D-D48BA2AFC205Q33387724-9E39059F-C3DD-4225-9AFD-5FA71E7862D0Q33402027-592151A1-9908-46BB-A1E9-A61D36A6711BQ33412382-3E6783DA-5BEC-40F1-B2FA-D724803C11D0Q33713555-D5B55395-5B58-4A22-85C8-02BF71073C6BQ33731308-2B9F5D84-8B22-4B43-8BC0-0A0D5FD7A4C2Q33849136-CBD3D97C-4AAE-405A-A732-12C417444A56Q33866272-34A27F5A-EB73-4FF1-9DB4-93BCC17B6EAEQ33870708-7CD110CD-6985-4EB6-84B2-F4F2E9647AA7Q33998662-5403A22C-E845-40BB-ABB3-1684784657DDQ34005936-CB0ED70D-EF7E-4978-98F4-12E4AC4FE536Q34029988-5396E974-C930-42D9-A637-585A9A247DDAQ34172595-5C2B3A94-5324-48AA-A2CD-44B725BDE86AQ34409039-A3020E8D-B07B-4465-8E79-AF75CC8274F6Q34429056-F6DE0B93-B0C5-45EB-A813-63390F42A726Q34515251-5868A3F1-952F-42A7-945D-A32888CA19A3
P2860
Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Prevalence of type 2 diabetes ...... nfection in the United States.
@en
Prevalence of type 2 diabetes ...... nfection in the United States.
@nl
type
label
Prevalence of type 2 diabetes ...... nfection in the United States.
@en
Prevalence of type 2 diabetes ...... nfection in the United States.
@nl
prefLabel
Prevalence of type 2 diabetes ...... nfection in the United States.
@en
Prevalence of type 2 diabetes ...... nfection in the United States.
@nl
P2093
P1476
Prevalence of type 2 diabetes ...... nfection in the United States.
@en
P2093
Brancati FL
Strathdee SA
Sulkowski MS
P304
P356
10.7326/0003-4819-133-8-200010170-00009
P407
P577
2000-10-01T00:00:00Z